Peking University People's Hospital: all 604 studies

Page 2 of 7. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.

• A Prediction Model in Pregnant Women With Aplastic AnemiaRecruitingNCT07101770
• The Effect of Different Delivery Positions on Pelvic Floor Function.Not yet recruitingNCT07081321Not applicable
• Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical StudyNot yet recruitingNCT07075250Phase 4
• Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic StrokeNot yet recruitingNCT07070193
• Longitudinal Observational Study on Immune ThrombocytopeniaNot yet recruitingNCT07068425
• The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)RecruitingNCT07065968Phase 2
• The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaNot yet recruitingNCT07064889Phase 2
• Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITPNot yet recruitingNCT07057778Phase 2
• Fucoidan in the Treatment of Active Rheumatoid ArthritisRecruitingNCT07045896Not applicable
• The Impact of Different Sedation Regimens on Hemodynamics in Patients Undergoing Mechanical Ventilation With ShockNot yet recruitingNCT07037615
• Observation and Study on the Application of Different Analgesic Regimens in Critically Ill Patients Without Mechanical VentilationNot yet recruitingNCT07031453
• Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High RiskNot yet recruitingNCT07010588Not applicable
• Long-Term Outcomes in SLE at Peking University People's HospitalRecruitingNCT07005479
• Therapy of Niacin for Rheumatoid ArthritisNot yet recruitingNCT07004725Phase 2
• Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAVNot yet recruitingNCT06986018Early Phase 1
• Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCTRecruitingNCT06984536Phase 2
• Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV ViremiaNot yet recruitingNCT06971913Phase 2
• ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast CancerRecruitingNCT06970912Phase 2
• Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCTRecruitingNCT06946654
• Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.RecruitingNCT06946602Not applicable
• Calcium Channel Blocker Amlodipine for Endometrial Cancer TherapyNot yet recruitingNCT06942377Phase 2
• Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung CancerRecruitingNCT06930807Not applicable
• Application-Assisted Weight Management in Endometrial Cancer Fertility PreservationNot yet recruitingNCT06901778Not applicable
• Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALLRecruitingNCT06880913Phase 1/2
• KPD Consolidation After ASCT in NDMM PatientsRecruitingNCT06879379Phase 2/3
• Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHLRecruitingNCT06874946Phase 1/2
• Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing PolychondritisRecruitingNCT06873100Phase 1/2
• Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid LeukemiaRecruitingNCT06869265Phase 2
• The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCTEnrolling by invitationNCT06864598
• Therapeutic Effect of Upadacitinib in Primary Sjögren's SyndromeNot yet recruitingNCT06862284Phase 2
• Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid LeukemiaRecruitingNCT06802718Phase 3
• BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
• B7-H3 NIR Imaging for Osteosarcoma SurgeryRecruitingNCT06778603Phase 1/2
• Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical StudyNot yet recruitingNCT06776198
• Dara-BCD for Rare MGRSNot yet recruitingNCT06771180Phase 2
• MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMTRecruitingNCT06748690Not applicable
• Endoscopic and Robotic NSM with Immediate Prosthesis Breast ReconstructionRecruitingNCT06748677
• Allo-HSCT vs ASCT in Adult T-LBLNot yet recruitingNCT06741813Not applicable
• Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT06727669
• Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor SurgeryRecruitingNCT06725082Phase 1
• Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of OsteosarcomaRecruitingNCT06714383Phase 2
• Prospective Study of Teclistamab in the Treatment of Systemic AL AmyloidosisRecruitingNCT06699394Not applicable
• Risk Stratification and MRD-driven Maintenance for MM After ASCTRecruitingNCT06697483Not applicable
• Research on the Application of Patient Navigation-based Management Model of Patients After LEEPNot yet recruitingNCT06695871Not applicable
• De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBCRecruitingNCT06692725
• Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung CancerNot yet recruitingNCT06682884Phase 2
• Haplo-HSCT for MyelofibrosisRecruitingNCT06674382Not applicable
• Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell LymphomaNot yet recruitingNCT06671717Not applicable
• Clinical Performance of Urine HPV Testing in MalesRecruitingNCT06671210
• An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell LeukemiaNot yet recruitingNCT06655519Phase 1
• Rapid dFLC Response Predict CHR in AL AmyloidosisRecruitingNCT06627309
• Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06581081Not applicable
• Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyRecruitingNCT06577909Phase 2
• Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow CytometryRecruitingNCT06569095
• The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in ChinaNot yet recruitingNCT06557304
• PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial CancerRecruitingNCT06549855Not applicable
• Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S DeficiencyNot yet recruitingNCT06531525Phase 2
• Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep LearningNot yet recruitingNCT06531200
• NAC for Hematopoietic Recovery in SAANot yet recruitingNCT06518044Phase 2
• Modified Second Haplo-transplantation for Graft FailureRecruitingNCT06512545Not applicable
• Second Haplo-transplantation for Graft FailureRecruitingNCT06512519Not applicable
• The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control StudyNot yet recruitingNCT06504420Phase 2
• The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer PatientsRecruitingNCT06503432
• The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in ChinaNot yet recruitingNCT06489184
• Antibiotic Exposure During Pregnancy Affects Infant Gut MicrobiotaRecruitingNCT06479941
• Interactions Between Environmental Exposures and Gut Microbiota in Early LifeRecruitingNCT06479928
• Fecal Microbiota Transplantation in the Treatment of Major LARSNot yet recruitingNCT06475430Not applicable
• Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial CancerRecruitingNCT06468215Not applicable
• Effects of Chinese Medicine and Lactobacillus in Persistent HPV InfectionRecruitingNCT06467942Not applicable
• Combined PRF of the Pudendal Nerve With Ganglion Impar Block Effectively Alleviates Pudendal NeuralgiaRecruitingNCT06461312Not applicable
• Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AMLRecruitingNCT06452732
• Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06426797Phase 2
• Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDDRecruitingNCT06418477Phase 2
• Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection TherapyNot yet recruitingNCT06418464Not applicable
• The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 DiabetesNot yet recruitingNCT06408532Phase 4
• The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBPRecruitingNCT06390306
• Respiratory Function Monitoring of Mechanical Ventilation in Patients With Chest Blunt InjuryNot yet recruitingNCT06386120
• Deep-learning Enabled Ultrasound Diagnosis of Anterior Talofibular Ligament InjuryNot yet recruitingNCT06373029
• A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.Not yet recruitingNCT06369935
• Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHDNot yet recruitingNCT06364319Phase 4
• The Effect of CPAP on Maternal and Infant Outcomes in Pregnant Women With OSASNot yet recruitingNCT06344702
• Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing SarcomaRecruitingNCT06340204Phase 1
• Dorsal Scapular Nerve Injection Combined With Muscle Needle ReleaseNot yet recruitingNCT06329960Not applicable
• Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant CellsRecruitingNCT06302465Not applicable
• MRD Response-adapted Allo-HSCT for Adverse-risk AMLRecruitingNCT06301425Not applicable
• Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin InhibitorsNot yet recruitingNCT06279494Phase 1/2
• Monitoring of Heart to Guide Myocardial Injury Patients to Wean From VentilationRecruitingNCT06240104Not applicable
• Clinical Effect of Individualized Exercise Prescription for Hypertension With 6-minute Walking Test (6MWT)Not yet recruitingNCT06219512Not applicable
• Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain ReactionRecruitingNCT06211166
• Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTRecruitingNCT06202625Phase 2/3
• Off-the-shelf CD123 CAR-NK for R/R AMLRecruitingNCT06201247Early Phase 1
• Teriflunomide for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06190145Phase 2
• The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06176911Phase 2
• Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing TreatmentRecruitingNCT06169449Not applicable
• A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseRecruitingNCT06134063Not applicable
• Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCTRecruitingNCT06130579Phase 2
• Endometrial Cancer Screening in High-risk PopulationsNot yet recruitingNCT06125886Not applicable
• Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingNCT06102863Phase 2
• Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCTNot yet recruitingNCT06075927Phase 1/2
• The Optimization of Conditioning Regimen for HLA Matched HSCT in SAARecruitingNCT06069180Phase 4

← Peking University People's Hospital overview and focus areas